DMD and Duchenne muscular dystrophy: Furthermore, skeletal muscle targeting was successfully achieved in a murine model of Duchenne Muscular Dystrophy using modified exosomes bearing CP05 (a specific CD63 exosomal anchor peptide) and M12 (muscle targeting peptide) and containing dystrophin splice–correcting morpholino oligomer with a reported increase in dystrophin expression in skeletal muscles and functional rescue without associated oligomer toxicity [272].